Register Medical Group Celebrates Anvisa Approval of Two New Semaglutide-Based Medicines
Register Medical Group celebrates a high-impact regulatory achievement for the Brazilian [...]
Leia mais Register Medical Group Celebrates Anvisa Approval of Two New Semaglutide-Based Medicines
Register Medical Group to Attend SOLACI & SBHCI 2026, Reinforcing Its Commitment to Innovation in Medical Devices
The Register Medical Group team will be attending Latin America’s leading interventional [...]
Leia mais Register Medical Group to Attend SOLACI & SBHCI 2026, Reinforcing Its Commitment to Innovation in Medical Devices
The Problem Isn’t Always ANVISA
More often than not, it’s the strategy that comes before the submission. When a regulatory [...]
Leia mais The Problem Isn’t Always ANVISA
Beyond the Numbers: What 4,000+ Product Registrations Really Mean
In the regulatory sector, numbers alone don’t tell the full story. Behind every successful [...]
Leia mais Beyond the Numbers: What 4,000+ Product Registrations Really Mean
Regulatory Success Starts Before Product Registration
Why building a compliant company is the smartest investment for market access in Brazil For many [...]
Leia mais Regulatory Success Starts Before Product Registration
Building Trust Beyond Borders: The Expertise Behind Every Regulatory Success
When people think about regulatory affairs, they often focus on the final outcome: an ANVISA [...]
Leia mais Building Trust Beyond Borders: The Expertise Behind Every Regulatory Success
